News

Resident News

Prapela Earns FDA Breakthrough Device Designation

By JLABS

Read full story
Other news

Johnson & Johnson Innovation Awards Bloomlife the First 1000 Days QuickFire Challenge

By JLABS

Read full story
Other news

Biotagenics Partners with University of Ottawa and CHEO on a $9.1 Million Project with Genome Canada to Develop Therapies for Inflammatory Bowel Disease

By JLABS

Read full story
In the media

Can Crowdsourcing and Collaboration Improve the Future of Human Health?

By Ben Wiegand

Read full story
Other news

Ensysce Biosciences has received Fast Track designation from the FDA for the development of abuse-resistant opioid drug PF614

By JLABS

Read full story
Other news

Cyclica CEO Naheed Kurji Says AI Could Create a New Paradigm for Drug Development

By JLABS

Read full story
Other news

Avicanna Completes 2nd Equity Financing & Welcomes New Strategic Shareholder

By JLABS

Read full story
In the media

Rising Real Estate Costs Are Forcing Life Science Startups To Get Comfortable With Co-Working

By Kyle Hagerty

Read full story
Other news

Ground-breaking tech identifies cognitive diseases with high accuracy

By JLABS

Read full story
Other news

Distributed Bio announces a deal to identify pre-optimized antibodies using their SuperHuman antibody library platform

By JLABS

Read full story
Other news

Ontario-developed technology for screening variant libraries comes of age

By JLABS

Read full story
Other news

Hear Bill Martin, CSO of Blackthorn Therapeutics discuss how #digitalhealth and #pharma are intersecting for CNS drug development, in our latest podcast

By JLABS

Read full story
Other news

Arcturus Therapeutics expands collaboration with Takeda Pharmaceuticals

By JLABS

Read full story
Other news

BlueRock Therapeutics and Hootsuite Top the 2018 Narwhal List

By JLABS

Read full story
Other news

Alzheimer’s Drug One-Step Closer to Reality After Krembil Team Signs Major Development Deal

By JLABS

Read full story